Bioorganic and Medicinal Chemistry p. 2107 - 2150 (2018)
Update date:2022-08-15
Topics:
Deaton, David N.
Haffner, Curt D.
Henke, Brad R.
Jeune, Michael R.
Shearer, Barry G.
Stewart, Eugene L.
Stuart, J. Darren
Ulrich, John C.
Starting from 4-amino-8-quinoline carboxamide lead 1a and scaffold hopping to the chemically more tractable quinazoline, a systematic exploration of the 2-substituents of the quinazoline ring, utilizing structure activity relationships and conformational constraint, resulted in the identification of 39 novel CD38 inhibitors. Eight of these analogs were 10–100-fold more potent human CD38 inhibitors, including the single digit nanomolar inhibitor 1am. Several of these molecules also exhibited improved therapeutic indices relative to hERG activity. A representative analog 1r exhibited suitable pharmacokinetic parameters for in vivo animal studies, including moderate clearance and good oral bioavailability. These inhibitor compounds will aid in the exploration of the enzymatic functions of CD38, as well as furthering the study of the therapeutic implications of NAD enhancement in metabolic disease models.
View MoreWuhan Sun-shine Bio-technology Corporation Limited
Contact:+862765522452
Address:武汉市东湖高新区高新二路388号生物医药加速器16栋501
Oren Hydrocarbons (Qingdao) Co., Ltd.
Contact:+86-532-68607667-801
Address:Room 3 # 302, No.9 Qingyun Road, Qingdao, China
Xinjiang Zhongtai Chemical Co., Ltd.
Contact:+86-991-8788172
Address:NO.78 XISHAN RD.URUMQI,CHINA
Hunan Zhongqi Pharmaceutical Co., Ltd
website:http://www.hnzqzy.com
Contact:0730-8722288 13807308622
Address:Wanjiafan Road ,Yueyang Economic And Technological Development Zone ,Hunan,PRC
RongCheng K&S Chemical Co.,Ltd
Contact:0631-7336369
Address:rongcheng ,shandong province china
Doi:10.1002/anie.201605380
(2016)Doi:10.1021/ol101838q
(2010)Doi:10.1021/jo101381r
(2010)Doi:10.1002/anie.201806271
(2018)Doi:10.1016/j.ejmech.2010.05.030
(2010)Doi:10.1002/jlcr.3910
(2021)